Introduction
============

If pulmonary arterial hypertension (PAH) occurs in pregnant women, it will lead to deterioration of hemodynamic status and cardiopulmonary function in the patients ([@b1-etm-0-0-5996]), with a 3-year mortality rate at 55% ([@b2-etm-0-0-5996]). Termination of pregnancy via caesarean section in intermediate and advanced stage of pregnancy is the major therapeutic method for the disease ([@b3-etm-0-0-5996]). With the progress in PAH research, some scholars found that in the perioperative period, the sex hormones of the puerperae can regulate the expressions of neurotransmitters and cell receptors, thus influencing the hemodynamics in the body ([@b4-etm-0-0-5996]). In the present study, the clinical data of 75 pregnant patients complicated with PAH were retrospectively reviewed, and three different anesthesia methods were compared and analyzed, so as to investigate the change rules of sex hormone levels as well as its correlation with hemodynamic changes in PAH patients with pregnancy in the perioperative period and to provide practical bases for selection of appropriate anesthesia methods in clinic.

Patients and methods
====================

### Research objects and grouping

A total of 75 pregnant patients complicated with severe PAH that were admitted and treated in Jining First People\'s Hospital (Jining, China) from January 2016 to January 2017 were selected and randomly divided into these three groups: The combined spinal/epidural anesthesia group (group I, n=25), the epidural anesthesia group (group II, n=25) and the general anesthesia group (group III, n=25). All patients underwent electrocardiogram, echocardiography, blood gas analysis, cardiac function measurement and other examinations and tests, and they met the diagnostic criteria related to severe PAH; it was detected via echocardiography that the systolic blood pressure of pulmonary artery was ≥70 mmHg. The patients did not take drugs containing sex hormones within 2 months. There were no significant differences in the clinical basic data among the three groups of patients (P\>0.05) ([Table I](#tI-etm-0-0-5996){ref-type="table"}). Signed informed consent was obtained from all the patients and their families. This study was approved by the Ethics Committee of Jining First People\'s Hospital.

### Research methods

The patients were given oxygen inhalation and intravenous infusion before the operation to maintain stable vital signs. In the perioperative period, vasoactive substances were used routinely to the patients to adjust the blood pressure, and antibiotics were applied to prevent infections.

Observation indexes
-------------------

### Monitoring of hemodynamic indexes at different time-points

Finometer^®^ PRO non-invasive hemodynamics monitor (Finapres Medical Systems B.V., Amsterdam, The Netherlands) was used to record the values of systolic blood pressure, diastolic blood pressure and blood oxygen saturation in the three groups at T~0~ (before anesthesia), T~1~ (after fetal birth) and T~2~ (at the end of the operation), of which the index difference Δ= T~1~ - T~0~ or T~2~ - T~0~.

### Observation of pregnancy outcomes of the three groups of patients

The time period of recording puerpera\'s death was from the start of the pregnancy to 42 days after the childbirth; the time period of recording the neonate\'s death was from the delivery to 28 days later; the neonatal asphyxia standard was based on the Apgar score, and it was determined that the Apgar score \<7 points at 1 min indicated neonatal asphyxia, of which 0--3 points represented for severe, and 4--7 points for mild.

### Observation of postoperative situations in the three groups

Days of intensive care unit (ICU) stay of the puerpera after the operation, days of ventilator support ventilation through continuous trachea intubation of the puerpera after the operation and days from the end of the operation to discharge from hospital of the puerpera after the operation.

### Detection of changes in hormone levels at different time-points in the three groups

Cobas e601 automatic electrochemiluminescence immunoassay analyzer (Roche, Basel, Switzerland) was used for electrochemiluminescence to detect the concentrations of plasma total testosterone (TT), estradiol (E2), follicle stimulating hormone (FSH), luteinizing hormone (LH), progestogen (PROG), human chorionic gonadotrophin (HCG) and prolactin (PRL) before the operation and at 24, 48 and 72 h after the operation.

### Statistical analysis

The data were entered into the SPSS 19.0 (SPSS, Inc., Chicago, IL, USA) for statistical analysis; the measurement data were presented as mean ± standard deviation (SD) and t-test was applied. The enumeration data were presented as n (%), and Chi-square test or Fishers exact test were used for inspections. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Comparisons of general conditions

There were no statistically significant differences in age, weight, pregnancy-labor history, gestational age, complications, cardiac disease history, cardiac function and other general information among the three groups (P\>0.05) ([Table I](#tI-etm-0-0-5996){ref-type="table"}).

### Comparisons of hemodynamic changes at different time-points among the three groups

At T1 and T2, the hemodynamic levels in the three groups were statistically different from those at T0 (P\<0.05); the systolic and diastolic blood pressure in groups I and II were higher than those in group III, and the Δ changes in the two groups were obviously smaller than that in group III (P\<0.05). At T1 and T2, the levels of blood oxygen saturation in groups I and II were lower than those in group III, and the Δ changes in the two groups were notably smaller than that in group III (P\<0.05) ([Table II](#tII-etm-0-0-5996){ref-type="table"}).

### Comparison of hospitalization after the operation among the three groups

The postoperative hospital stay, staying time in ICU and time of mechanical ventilation of the pregnant patients in groups I and II were obviously shorter than those in group III (P\<0.05); the differences between groups I and II were not statistically significant (P\>0.05) ([Table III](#tIII-etm-0-0-5996){ref-type="table"}).

### Comparisons of pregnancy outcomes among the three groups

The results of neonatal mortality rate, neonatal asphyxia rate and maternal mortality rate in the three groups showed that the indexes in group I were 4.0, 12.0 and 0.0%, respectively; the neonatal mortality rate, neonatal asphyxia rate and maternal mortality rate in group II were 0.0, 12.0 and 4.0%, respectively, and those in group II were 0.0, 16.0 and 4.0%, respectively. There were no statistically significant differences in comparison between the groups (P\>0.05) ([Table IV](#tIV-etm-0-0-5996){ref-type="table"}).

### Changes in sex hormone levels in each group at different time-points

The levels of E2, HCG and TT in the three groups of patients at each time-point after the operation were decreased significantly compared with those before the operation, while the levels FSH, LH and PROG were increased to some extent after the operation, of which the differences in the decreasing degrees of E2 and TT at each time-point were statistically significant (P\<0.05). Moreover, the E2 level in group III at each time-point was lower than those in groups II and I, and at 72 h after the operation, the difference in comparison between the groups was statistically significant. The PROG level in group III at each time-point was elevated compared with those in groups I and II, but there was no statistically significant difference (P\>0.05) ([Table V](#tV-etm-0-0-5996){ref-type="table"}).

### Correlation analysis results of sex hormones and blood pressure

With the concentrations of TT, E2, LH, FSH, PROG, PRL and HCG as the independent variables and with systolic blood pressure and diastolic blood pressure as the dependent variables, the analysis results indicated that the contents of E2 and TT were directly correlated with blood pressure, and the difference was statistically significant (P\<0.05) ([Table VI](#tVI-etm-0-0-5996){ref-type="table"}).

Discussion
==========

The increase in cardiac output and decrease in resistance of all blood vessels (including pulmonary vessels) at the same time in the normal pregnant women can maintain the mean pulmonary artery pressure (mPAP) during pregnancy at the level before the pregnancy ([@b5-etm-0-0-5996]). However, for pregnant patients complicated with PAH, the sharp changes in blood volume during labor and after childbirth, as well as decreased in vena cava pressure may induce right heart failure; therefore, in most cases, caesarean section is conducted to terminate pregnancy in intermediate and advanced stage ([@b6-etm-0-0-5996]--[@b8-etm-0-0-5996]). Intravertebral anesthesia is the best way to terminate pregnancy for pregnant women complicated with PAH, which includes combined spinal/epidural anesthesia and epidural anesthesia ([@b9-etm-0-0-5996]). Intravertebral anesthesia can effectively decrease the peripheral vascular resistance (PVR) and reduce returned blood volume, thus lowering the myocardial oxygen consumption; during the anesthesia process, trachea intubation is not needed, so that the interference of mechanical ventilation in blood circulation can be avoided, and the risk of pulmonary infection is reduced. General anesthesia decreases the occurrence of acute pulmonary edema in the patients through the analgesia, sedation and muscle relaxation effects; the application of ventilator support improves the oxygen supply to the patients, but it increases the risk of pulmonary infection at the same time; drugs have different degrees of inhibition on the patients\' cardiac functions ([@b10-etm-0-0-5996],[@b11-etm-0-0-5996]).

The results of the present study showed that, whether intravertebral anesthesia (including epidural anesthesia and combined spinal/epidural anesthesia) or general anesthesia was adopted, the systolic blood pressure and diastolic blood pressure after anesthesia were decreased remarkably compared with those before anesthesia (P\<0.05). The changes in systolic blood pressure and diastolic blood pressure of the pregnant patients in groups II and I were obviously smaller than those in group III (P\<0.05), indicating that intravertebral anesthesia has milder impacts on the hemodynamics, which can effectively avoid rapid drop in blood pressure of the pregnant patients caused by fetal birth during caesarean section. The analysis on the outcomes of the three groups of patients found that there were no statistically significant differences in neonatal mortality rate, neonatal asphyxia rate and maternal mortality rate (P\<0.05). The time of postoperative hospital stay, ICU stay and mechanical ventilation time in groups II and I were obviously shorter than those in group III, and the differences were statistically significant (P\<0.05).

In normal puerperae, the sex hormone levels are elevated rapidly after pregnancy; after labor, the levels of estrogen and so on are lowered greatly and returned gradually to normal at 6 weeks after labor; during the whole pregnancy and labor, E2, FSH, LH, PG, PRL, TT, HCG and other sex hormones play complex regulatory roles in pregnancy ([@b12-etm-0-0-5996]). The impact of sex hormone changes during pregnancy on PAH has not been elaborated completely. The latest research results have revealed that E2 and testosterone can suppress the endothelin activity by improving the activities of endothelial nitric oxide (NO) synthase and prostacyclin synthase, thus inhibiting the pulmonary vasoconstriction ([@b13-etm-0-0-5996],[@b14-etm-0-0-5996]). It was found through estrogen replacement treatment test that the ejection fraction of the right ventricular (RV) is related to E2 level ([@b9-etm-0-0-5996]), and E2 is beneficial to RV functions of PAH patients during pregnancy, that is, the processes mediated by E2 receptor, which are good for myocardial metabolism, inflammation, fibration, stromal remodeling and cell apoptosis, have a correlation with its effect of improving cardiac function and mortality rate ([@b15-etm-0-0-5996]--[@b17-etm-0-0-5996]). It was reported in literature that the decrease in PVR may be associated with the mediation of sex hormones ([@b18-etm-0-0-5996]); studies have indicated that the 'withdrawal phenomenon' of estrogen, after labor may lead to pulmonary vasoconstriction ([@b6-etm-0-0-5996]). In this experiment, the hormone levels of the patients at different time-points of perioperative period were measured, and it was discovered that the levels of E2, HCG and TT in the three groups of patients at each time-point after the operation were decreased significantly compared with those before the operation, while the levels FSH, LH and PROG were increased to some extent after the operation, of which the differences in the decreasing degrees of E2 and TT at each time-point were statistically significant (P\<0.05). Moreover, the E2 level in group III at each time-point was lower than those in groups II and I, and at 72 h after the operation, the difference in comparison between the groups was statistically significant. In combination with the hemodynamics examination results, the changes in systolic blood pressure and diastolic blood pressure of the pregnant patients in groups II and I were obviously smaller than those in group III. Further statistical analysis revealed that the contents of sex hormones E2 and TT were directly related to arterial blood pressure, indicating that the decrease in E2 and TT may be one of the reasons for greater fluctuations in postoperative hemodynamics in group III than those in the other two groups; timely utilization of estrogen replacement therapy can ameliorate the patients\' conditions.

In conclusion, for pregnant patients complicated with severe PAH, there is no significant difference in pregnancy outcomes among the three anesthesia methods, but the changes in hemodynamics of patients in epidural anesthesia group and combined spinal/epidural anesthesia group are more stable; meanwhile, the mechanical ventilation time, ICU stay and postoperative hospital stay are shortened remarkably; therefore, intravertebral anesthesia is preferred in case of patients without contraindication of the anesthesia.
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###### 

Comparisons of general clinical data among the three groups of puerperae.

  Items                            Group I (n=25)   Group II (n=25)   Group III (n=25)
  -------------------------------- ---------------- ----------------- ------------------
  Age (years)                      28.11±4.01       27.58±4.92        27.88±4.24
  Weight (kg)                      60.22±3.38       60.77±3.45        59.58±4.43
  Gestational age (weeks)          30.38±4.98       30.78±4.02        30.44±4.35
  Primiparity, n (%)               20 (80.00)       21 (84.00)        19 (76.00)
  Cardiac function grading                                            
    Grade III                      14 (56.00)       13 (52.00)        14 (56.00)
    Grade IV                       10 (40.00)       12 (48.00)        11 (44.00)
  Type of cardiac disease, n (%)                                      
    Congenital heart disease       15 (60.00)       13 (52.00)        14 (56.00)
    Rheumatic heart disease        10 (40.00)       12 (48.00)        11 (44.00)
  Complication, n (%)                                                 
    Arrhythmia                     13 (52.00)       7 (58.33)         9 (60.00)
    Hypoproteinemia                19 (76.00)       10 (83.33)        12 (80.00)
    Pulmonary infection            8 (32.00)        9 (36.00)         7 (28.00)

###### 

Comparisons of hemodynamic changes at different time-points among the three groups of patients (n=25).

  Groups   Systolic blood pressure                                      Δ Systolic blood pressure                                                                               Diastolic blood pressure                                   Δ Diastolic blood pressure                                                                             Blood oxygen saturation                                    Δ Blood oxygen saturation
  -------- ------------------------------------------------------------ ------------------------------------------------------------------------------------------------------- ---------------------------------------------------------- ------------------------------------------------------------------------------------------------------ ---------------------------------------------------------- ---------------------------------------------------------
  T0                                                                                                                                                                                                                                                                                                                                                                                                         
    I      154.22±15.32                                                                                                                                                         90.12±6.38                                                                                                                                                        90.02±6.98                                                 
    II     151.45±16.52                                                                                                                                                         89.91±6.65                                                                                                                                                        89.98±5.83                                                 
    III    156.70±15.88                                                                                                                                                         88.00±8.02                                                                                                                                                        89.02±6.78                                                 
  T1                                                                                                                                                                                                                                                                                                                                                                                                         
    I      136.70±8.97^[a](#tfn1-etm-0-0-5996){ref-type="table-fn"}^    16.41±6.65^[b](#tfn2-etm-0-0-5996){ref-type="table-fn"},[c](#tfn3-etm-0-0-5996){ref-type="table-fn"}^   84.91±4.10^[a](#tfn1-etm-0-0-5996){ref-type="table-fn"}^   4.28±1.39^[b](#tfn2-etm-0-0-5996){ref-type="table-fn"},[c](#tfn3-etm-0-0-5996){ref-type="table-fn"}^   91.88±3.43^[a](#tfn1-etm-0-0-5996){ref-type="table-fn"}^   3.22±1.73^[b](#tfn2-etm-0-0-5996){ref-type="table-fn"}^
    II     131.12±8.28^[a](#tfn1-etm-0-0-5996){ref-type="table-fn"}^    21.79±7.01^[b](#tfn2-etm-0-0-5996){ref-type="table-fn"}^                                                81.77±4.98^[a](#tfn1-etm-0-0-5996){ref-type="table-fn"}^   7.02±2.03^[b](#tfn2-etm-0-0-5996){ref-type="table-fn"}^                                                92.25±3.93^[a](#tfn1-etm-0-0-5996){ref-type="table-fn"}^   3.03±1.92^[b](#tfn2-etm-0-0-5996){ref-type="table-fn"}^
    III    123.68±9.10^[a](#tfn1-etm-0-0-5996){ref-type="table-fn"}^    31.35±5.61                                                                                              77.33±5.05^[a](#tfn1-etm-0-0-5996){ref-type="table-fn"}^   7.98±3.05                                                                                              95.22±4.11^[a](#tfn1-etm-0-0-5996){ref-type="table-fn"}^   8.02±1.98
  T2                                                                                                                                                                                                                                                                                                                                                                                                         
    I      127.72±7.18^[a](#tfn1-etm-0-0-5996){ref-type="table-fn"}^    28.03±5.00^[b](#tfn2-etm-0-0-5996){ref-type="table-fn"},[c](#tfn3-etm-0-0-5996){ref-type="table-fn"}^   79.19±6.52^[a](#tfn1-etm-0-0-5996){ref-type="table-fn"}^   8.79±2.88^[b](#tfn2-etm-0-0-5996){ref-type="table-fn"},[c](#tfn3-etm-0-0-5996){ref-type="table-fn"}^   93.92±3.48^[a](#tfn1-etm-0-0-5996){ref-type="table-fn"}^   5.04±2.22^[b](#tfn2-etm-0-0-5996){ref-type="table-fn"}^
    II     119.88±8.05^[a](#tfn1-etm-0-0-5996){ref-type="table-fn"}^    31.49±4.98^[b](#tfn2-etm-0-0-5996){ref-type="table-fn"}^                                                76.48±4.50^[a](#tfn1-etm-0-0-5996){ref-type="table-fn"}^   11.77±1.28^[b](#tfn2-etm-0-0-5996){ref-type="table-fn"}^                                               94.77±2.56^[a](#tfn1-etm-0-0-5996){ref-type="table-fn"}^   5.62±3.10^[b](#tfn2-etm-0-0-5996){ref-type="table-fn"}^
    III    113.12±12.33^[a](#tfn1-etm-0-0-5996){ref-type="table-fn"}^   43.35±6.77                                                                                              73.15±4.98^[a](#tfn1-etm-0-0-5996){ref-type="table-fn"}^   13.88±2.70                                                                                             97.12±4.48^[a](#tfn1-etm-0-0-5996){ref-type="table-fn"}^   9.78±2.68

Comparison with that at T0

comparison with that in group III

comparison with that in group II; P\<0.05 suggests that the difference is statistically significant.

###### 

Comparison of hospitalization after the operation among the three groups of pregnant patients (mean ± SD).

  Groups   No.   Postoperative hospital stay                               ICU staying time                                          Time of mechanical ventilation
  -------- ----- --------------------------------------------------------- --------------------------------------------------------- ---------------------------------------------------------
  I        25    8.16±2.53^[a](#tfn4-etm-0-0-5996){ref-type="table-fn"}^   3.35±2.10^[a](#tfn4-etm-0-0-5996){ref-type="table-fn"}^   2.01±1.16^[a](#tfn4-etm-0-0-5996){ref-type="table-fn"}^
  II       25    8.77±2.28^[a](#tfn4-etm-0-0-5996){ref-type="table-fn"}^   4.01±1.78^[a](#tfn4-etm-0-0-5996){ref-type="table-fn"}^   2.15±1.38^[a](#tfn4-etm-0-0-5996){ref-type="table-fn"}^
  III      25    15.88±9.45                                                7.99±5.87                                                 5.66±4.23

P\<0.05 compared with group III.

###### 

Comparisons of pregnancy outcomes among the three groups of pregnant patients, n (%).

  Groups   No.   Neonatal death   Neonatal asphyxia   Maternal death
  -------- ----- ---------------- ------------------- ----------------
  I        25    1 (4.0)          3 (12.0)            0 (0.0)
  II       25    0 (0.0)          3 (12.0)            1 (4.0)
  III      25    0 (0.0)          4 (16.0)            1 (4.0)

###### 

Comparisons of sex hormone levels at different time-points among the three groups of patients (mean ± SD, ng/l).

  Groups       Time                      E2                                                                                                      TT                                                              HCG         FSH         LH            PROG             PRL
  ------------ ------------------------- ------------------------------------------------------------------------------------------------------- --------------------------------------------------------------- ----------- ----------- ------------- ---------------- ----------------
  I (n=25)     Before operation          36.18±8.88                                                                                              3880.09±1100.64                                                 5.64±3.77   3.11±1.33   23.16±12.58   761.12±348.21    522.22±218.66
               At the end of operation   30.12±9.01^[a](#tfn5-etm-0-0-5996){ref-type="table-fn"}^                                                3011.18±1313.46^[a](#tfn5-etm-0-0-5996){ref-type="table-fn"}^   5.33±3.45   3.50±1.79   22.78±12.68   860.12±328.23    400.00±221.66
               24 h after operation      26.25±9.88^[a](#tfn5-etm-0-0-5996){ref-type="table-fn"}^                                                3077.45±1200.45^[a](#tfn5-etm-0-0-5996){ref-type="table-fn"}^   4.48±1.39   4.30±2.20   25.00±12.35   940.13±209.98    459.33±155.65
               48 h after operation      24.15±9.12^[a](#tfn5-etm-0-0-5996){ref-type="table-fn"}^                                                2244.33±1225.38^[a](#tfn5-etm-0-0-5996){ref-type="table-fn"}^   5.09±3.11   5.31±2.98   27.02±14.58   1000.88±320.23   420.26±166.85
               72 h after operation      22.23±7.78^[a](#tfn5-etm-0-0-5996){ref-type="table-fn"},[b](#tfn6-etm-0-0-5996){ref-type="table-fn"}^   1798.66±1235.16^[a](#tfn5-etm-0-0-5996){ref-type="table-fn"}^   3.44±1.55   5.54±3.03   32.12±7.56    1030.11±300.88   330.36.±188.10
  II (n=25)    Before operation          37.16±9.18                                                                                              3900.09±1157.64                                                 5.99±4.01   3.07±1.28   23.77±13.59   770.12±355.23    530.22±228.78
               At the end of operation   29.02±9.48^[a](#tfn5-etm-0-0-5996){ref-type="table-fn"}^                                                3065.18±1399.76^[a](#tfn5-etm-0-0-5996){ref-type="table-fn"}^   5.58±3.66   3.69±1.86   22.48±13.87   880.15±340.15    410.23±210.12
               24 h after operation      27.45±10.11^[a](#tfn5-etm-0-0-5996){ref-type="table-fn"}^                                               3100.55±1251.75^[a](#tfn5-etm-0-0-5996){ref-type="table-fn"}^   4.39±1.56   4.45±2.28   25.56±13.38   960.54±218.40    470.54±133.32
               48 h after operation      25.77±9.00^[a](#tfn5-etm-0-0-5996){ref-type="table-fn"}^                                                2299.47±1289.44^[a](#tfn5-etm-0-0-5996){ref-type="table-fn"}^   5.14±3.47   5.55±3.10   27.76±15.66   1010.28±312.18   441.23±160.88
               72 h after operation      23.17±6.68^[a](#tfn5-etm-0-0-5996){ref-type="table-fn"},[b](#tfn6-etm-0-0-5996){ref-type="table-fn"}^   1818.87±1300.15^[a](#tfn5-etm-0-0-5996){ref-type="table-fn"}^   3.28±1.35   5.36±3.18   31.23±7.15    1040.63±308.07   350.11±178.99
  III (n=25)   Before operation          35.12±14.13                                                                                             3988.10±1173.54                                                 5.88±3.97   2.98±1.13   22.98±13.47   793.48±370.45    543.38±238.13
               At the end of operation   26.52±10.48^[a](#tfn5-etm-0-0-5996){ref-type="table-fn"}^                                               3059.46±1333.45^[a](#tfn5-etm-0-0-5996){ref-type="table-fn"}^   5.42±3.43   3.65±1.73   23.03±14.48   890.35±338.25    399.13±158.43
               24 h after operation      24.36±9.77^[a](#tfn5-etm-0-0-5996){ref-type="table-fn"}^                                                3120.48±1322.35^[a](#tfn5-etm-0-0-5996){ref-type="table-fn"}^   4.25±1.37   4.40±2.15   28.35±13.32   978.43±223.40    480.02±122.14
               48 h after operation      20.18±8.96^[a](#tfn5-etm-0-0-5996){ref-type="table-fn"}^                                                2335.40±1310.46^[a](#tfn5-etm-0-0-5996){ref-type="table-fn"}^   5.03±3.54   5.12±2.91   28.03±13.65   1040.44±310.11   428.12±180.44
               72 h after operation      16.33±4.89^[a](#tfn5-etm-0-0-5996){ref-type="table-fn"}^                                                1799.93±1388.51^[a](#tfn5-etm-0-0-5996){ref-type="table-fn"}^   3.18±1.33   5.28±3.13   33.12±7.99    1069.87±298.89   298.15±203.20

Compared with that at each time-point before the operation within groups, P\<0.05

intergroup comparison at the time-point, P\<0.05.

###### 

Correlation analysis of serum inflammatory factors and pulmonary functions in case of pregnancy complicated with severe PAH (r value).

  Relevant variable          TT                                                     E2                                                     HCG      PRL      FSH      LH       PROG
  -------------------------- ------------------------------------------------------ ------------------------------------------------------ -------- -------- -------- -------- --------
  Systolic blood pressure    −1.010^[a](#tfn8-etm-0-0-5996){ref-type="table-fn"}^   −0.792^[a](#tfn8-etm-0-0-5996){ref-type="table-fn"}^   −0.170   −0.313   −0.412   −0.312   −0.189
  Diastolic blood pressure   −0.811^[a](#tfn8-etm-0-0-5996){ref-type="table-fn"}^   −0.688^[a](#tfn8-etm-0-0-5996){ref-type="table-fn"}^   −0.179   −0.289   −0.403   −0.303   −0.221

TT, total testosterone; E2, estradiol; FSH, follicle stimulating hormone; LH, luteinizing hormone; PROG, progestogen; HCG, human chorionic gonadotrophin; PRL, prolactin.

Significant correlationship.
